Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.58 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.58 |
| ▸ | MAOA | P21397 | 1/20 | 0.58 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | HTR2B | P41595 | 1/20 | 0.58 |
| ▸ | RAPGEF4 | Q8WZA2 | 15/20 | 0.53 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 1/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1314635 | 0.97 | CYP3A4 (0.55) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL27561995 | 0.97 | CYP3A4 (0.55) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL2972493 | 0.97 | CYP3A4 (0.55) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| Sulfur Dioxide SCHEMBL10838499 | 0.88 | CYP3A4 (0.48) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL11876475 | 0.84 | RAPGEF4 (0.58) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL23121642 | 0.80 | HTR2B (0.41) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL11496778 | 0.80 | CYP3A4 (0.46) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL22922896 | 0.80 | ALDH1A1 (0.52) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL13550088 | 0.80 | RAPGEF4 (0.43) | CYP3A4CHRM1ALOX15MAOATBXA2R | |
| SCHEMBL30433819 | 0.80 | CYP3A4 (0.52) | CYP3A4CHRM1ALOX15MAOATBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 644 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4683917-A1 | A METHOD FOR THE PREPARATION OF ANTHRANILIC DIAMIDES | PI Industries Ltd. (IN) | 2026-01-28 | — | — | EP | claimed |
| CN-120004697-A | Preparation method of OrgVO material and application of OrgVO material as secondary battery anode material | 同济大学 | 2025-05-16 | — | — | CN | claimed |
| CN-119285468-B | High-selectivity preparation method of 4- (4-acetyl cumyl) phenol ester compound | 天津久日半导体材料有限公司 | 2025-04-01 | — | — | CN | claimed |
| CN-119613311-A | High-selectivity synthesis method of (3S, 4R) -3- (N-benzyl-N-cyclopropyl) aminomethyl-4-hydroxypyrrolidine-1-carboxylic acid benzyl ester | 武汉理工大学 | 2025-03-14 | — | — | CN | claimed |
| CN-119285468-A | High-selectivity preparation method of 4- (4-acetyl cumyl) phenol ester compound | 天津久日半导体材料有限公司 | 2025-01-10 | — | — | CN | claimed |
| CN-119219455-A | Aromatic ring hydrogen-deuterium exchange reaction catalytic system and preparation method of deuterated aromatic hydrocarbon | 国科大杭州高等研究院 | 2024-12-31 | — | — | CN | claimed |
| WO-2024194896-A1 | A METHOD FOR THE PREPARATION OF ANTHRANILIC DIAMIDES | PI INDUSTRIES LTD. (IN) | 2024-09-26 | — | — | WO | claimed |
| CN-112094296-B | Preparation method of bis (2, 4, 6-trimethylbenzoyl) phenylphosphine oxide | 山东久日化学科技有限公司 | 2024-03-29 | — | — | CN | claimed |
| CN-115160362-B | Preparation method of 2,4, 6-trimethylbenzoyl diphenyl phosphine oxide | 天津久日新材料股份有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-115160362-A | Preparation method of 2,4, 6-trimethylbenzoyl diphenyl phosphine oxide | 天津久日新材料股份有限公司 | 2022-10-11 | — | — | CN | claimed |
| CN-101323597-B | Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde | ANHUI QINGYUN PHARMACEUTICAL AND CHEMICAL CO LTD | 2012-09-05 | — | — | CN | claimed |
| CN-101508684-A | Synthesis of cinepazide maleate | UNIV DALIAN TECH (CN) | 2009-08-19 | — | — | CN | claimed |
| CN-101323597-A | Preparation of 4-(4-fluorophenyl)-6-isopropyl-2-(N-methyl-N-methylsulfonyl amido) pyrimidine-5-formaldehyde | ANHUI QINGYUN PHARMACEUTICAL A (CN) | 2008-12-17 | — | — | CN | claimed |
| US-7087548-B2 | Preparation and use of a heterogeneous rhodium catalyst for the hydrogenation of a double bond of an α-β-unsaturated carbonyl compound | CHEMI SPA (IT) | 2006-08-08 | — | — | US | claimed |
| WO-2005113498-A1 | ADRENERGIC RECEPTOR ANTAGONISTS | RANBAXY LABORATORIES LIMITED (IN) | 2005-12-01 | — | — | WO | claimed |
| US-20050033092-A1 | Preparation and use of a heterogeneous catalyst for the hydrogenation of a double bond of an alpha-beta-unsaturated carbonyl compound | CHEMI SPA (IT) | 2005-02-10 | — | — | US | claimed |
| EP-1373289-A1 | 9-AMINO-14-MEMBERED MACROLIDE DERIVED FROM LEUCOMYCIN | Enanta Pharmaceuticals, Inc. (US) | 2004-01-02 | — | — | EP | claimed |
| WO-2002081493-A1 | 9-AMINO-14-MEMBERED MACROLIDE DERIVED FROM LEUCOMYCIN | ENANTA PHARMACEUTICALS, INC. (US) | 2002-10-17 | — | — | WO | claimed |
| EP-0121489-B1 | 3',4',5,7-TETRAHYDROXYFLAVONE DERIVATIVES, PROCESS FOR THEIR PREPARATION AND THEIR THERAPEUTICAL USE | CORTIAL S.A. (FR) | 1986-11-26 | — | — | EP | claimed |
| US-4140695-A | Process for producing copper phthalocyanines | IHARA CHEMICAL INDUSTRY CO., LTD. (JP) | 1979-02-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050033092-A1 | Preparation and use of a heterogeneous catalyst for the hydrogenation of a double bond of an alpha-beta-unsaturated carbonyl compound | CYP8B1, HADHB, HBB | CYP3A4 476/4885CHRM1 191/4885ALOX15 214/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.